Global and Japan Adoptive Cell Transfer Therapy Market Size, Status and Forecast 2021-2027

Global and Japan Adoptive Cell Transfer Therapy Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NK
1.2.3 LAK
1.2.4 DC
1.2.5 CIK
1.2.6 CTL
1.2.7 TIL
1.2.8 TCR-T
1.2.9 CAR-T
1.3 Market by Application
1.3.1 Global Adoptive Cell Transfer Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Lymphocytic Leukemia
1.3.3 NHL
1.3.4 Melanoma
1.3.5 Bladder Cancer
1.3.6 Lung Cancer
1.3.7 Head and Neck Cancer
1.3.8 Multiple Myeloma
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Transfer Therapy Market Perspective (2016-2027)
2.2 Adoptive Cell Transfer Therapy Growth Trends by Regions
2.2.1 Adoptive Cell Transfer Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adoptive Cell Transfer Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Adoptive Cell Transfer Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Adoptive Cell Transfer Therapy Industry Dynamic
2.3.1 Adoptive Cell Transfer Therapy Market Trends
2.3.2 Adoptive Cell Transfer Therapy Market Drivers
2.3.3 Adoptive Cell Transfer Therapy Market Challenges
2.3.4 Adoptive Cell Transfer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue (2016-2021)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Transfer Therapy Revenue
3.4 Global Adoptive Cell Transfer Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Transfer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Transfer Therapy Revenue in 2020
3.5 Adoptive Cell Transfer Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Transfer Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Transfer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Transfer Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Type (2016-2021)
4.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2022-2027)
5 Adoptive Cell Transfer Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Application (2016-2021)
5.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Adoptive Cell Transfer Therapy Market Size (2016-2027)
6.2 North America Adoptive Cell Transfer Therapy Market Size by Type
6.2.1 North America Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
6.2.2 North America Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
6.2.3 North America Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
6.3 North America Adoptive Cell Transfer Therapy Market Size by Application
6.3.1 North America Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
6.3.2 North America Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
6.3.3 North America Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
6.4 North America Adoptive Cell Transfer Therapy Market Size by Country
6.4.1 North America Adoptive Cell Transfer Therapy Market Size by Country (2016-2021)
6.4.2 North America Adoptive Cell Transfer Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Adoptive Cell Transfer Therapy Market Size (2016-2027)
7.2 Europe Adoptive Cell Transfer Therapy Market Size by Type
7.2.1 Europe Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
7.2.2 Europe Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
7.2.3 Europe Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Application
7.3.1 Europe Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
7.3.2 Europe Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
7.3.3 Europe Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
7.4 Europe Adoptive Cell Transfer Therapy Market Size by Country
7.4.1 Europe Adoptive Cell Transfer Therapy Market Size by Country (2016-2021)
7.4.2 Europe Adoptive Cell Transfer Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size (2016-2027)
8.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type
8.2.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application
8.3.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region
8.4.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Adoptive Cell Transfer Therapy Market Size (2016-2027)
9.2 Latin America Adoptive Cell Transfer Therapy Market Size by Type
9.2.1 Latin America Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
9.3 Latin America Adoptive Cell Transfer Therapy Market Size by Application
9.3.1 Latin America Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
9.4 Latin America Adoptive Cell Transfer Therapy Market Size by Country
9.4.1 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size (2016-2027)
10.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type
10.2.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application
10.3.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country
10.4.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Introduction
11.1.4 Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Details
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Introduction
11.2.4 Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.2.5 Kite Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Adoptive Cell Transfer Therapy Introduction
11.3.4 Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.4.5 Juno Therapeutics Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Introduction
11.5.4 Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.5.5 Celgene Corporation Recent Development
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Details
11.6.2 CARsgen Therapeutics Business Overview
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Introduction
11.6.4 CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.6.5 CARsgen Therapeutics Recent Development
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Details
11.7.2 Sorrento Therapeutics Business Overview
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Introduction
11.7.4 Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.7.5 Sorrento Therapeutics Recent Development
11.8 Legend Biotech
11.8.1 Legend Biotech Company Details
11.8.2 Legend Biotech Business Overview
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Introduction
11.8.4 Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.8.5 Legend Biotech Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Details
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Introduction
11.9.4 Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Details
11.10.2 Aurora Biopharma Business Overview
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Introduction
11.10.4 Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.10.5 Aurora Biopharma Recent Development
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Details
11.11.2 Autolus Therapeutics PLC Business Overview
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Introduction
11.11.4 Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.11.5 Autolus Therapeutics PLC Recent Development
11.12 Bluebird
11.12.1 Bluebird Company Details
11.12.2 Bluebird Business Overview
11.12.3 Bluebird Adoptive Cell Transfer Therapy Introduction
11.12.4 Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.12.5 Bluebird Recent Development
11.13 Carina Biotech
11.13.1 Carina Biotech Company Details
11.13.2 Carina Biotech Business Overview
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Introduction
11.13.4 Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.13.5 Carina Biotech Recent Development
11.14 Athenex
11.14.1 Athenex Company Details
11.14.2 Athenex Business Overview
11.14.3 Athenex Adoptive Cell Transfer Therapy Introduction
11.14.4 Athenex Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.14.5 Athenex Recent Development
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Introduction
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Details
11.16.2 Hengrui Yuanzheng Business Overview
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Introduction
11.16.4 Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.16.5 Hengrui Yuanzheng Recent Development
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Details
11.17.2 Eureka Therapeutics Business Overview
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Introduction
11.17.4 Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.17.5 Eureka Therapeutics Recent Development
11.18 WuXi Juno
11.18.1 WuXi Juno Company Details
11.18.2 WuXi Juno Business Overview
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Introduction
11.18.4 WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.18.5 WuXi Juno Recent Development
11.18 Shenzhen Inno Immunity
11.25.1 Shenzhen Inno Immunity Company Details
11.25.2 Shenzhen Inno Immunity Business Overview
11.25.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Introduction
11.25.4 Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.25.5 Shenzhen Inno Immunity Recent Development
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Details
11.20.2 Shenzhen Binde Bio Business Overview
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Introduction
11.20.4 Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.20.5 Shenzhen Binde Bio Recent Development
11.21 Kerui Bio
11.21.1 Kerui Bio Company Details
11.21.2 Kerui Bio Business Overview
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Introduction
11.21.4 Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.21.5 Kerui Bio Recent Development
11.22 Adaptimmune
11.22.1 Adaptimmune Company Details
11.22.2 Adaptimmune Business Overview
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Introduction
11.22.4 Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.22.5 Adaptimmune Recent Development
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Details
11.23.2 Altor Bioscience Corporation Business Overview
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Introduction
11.23.4 Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.23.5 Altor Bioscience Corporation Recent Development
11.24 Cellectis
11.24.1 Cellectis Company Details
11.24.2 Cellectis Business Overview
11.24.3 Cellectis Adoptive Cell Transfer Therapy Introduction
11.24.4 Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.24.5 Cellectis Recent Development
11.25 Takara Bio
11.25.1 Takara Bio Company Details
11.25.2 Takara Bio Business Overview
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Introduction
11.25.4 Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.25.5 Takara Bio Recent Development
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Details
11.26.2 Unum Therapeutics Business Overview
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Introduction
11.26.4 Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021)
11.26.5 Unum Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NK
Table 3. Key Players of LAK
Table 4. Key Players of DC
Table 5. Key Players of CIK
Table 6. Key Players of CTL
Table 7. Key Players of TIL
Table 8. Key Players of TCR-T
Table 9. Key Players of CAR-T
Table 10. Global Adoptive Cell Transfer Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Adoptive Cell Transfer Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Adoptive Cell Transfer Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Adoptive Cell Transfer Therapy Market Share by Regions (2016-2021)
Table 14. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Adoptive Cell Transfer Therapy Market Share by Regions (2022-2027)
Table 16. Adoptive Cell Transfer Therapy Market Trends
Table 17. Adoptive Cell Transfer Therapy Market Drivers
Table 18. Adoptive Cell Transfer Therapy Market Challenges
Table 19. Adoptive Cell Transfer Therapy Market Restraints
Table 20. Global Adoptive Cell Transfer Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Adoptive Cell Transfer Therapy Market Share by Players (2016-2021)
Table 22. Global Top Adoptive Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Transfer Therapy as of 2020)
Table 23. Ranking of Global Top Adoptive Cell Transfer Therapy Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Adoptive Cell Transfer Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Adoptive Cell Transfer Therapy Product Solution and Service
Table 27. Date of Enter into Adoptive Cell Transfer Therapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2016-2021)
Table 31. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Adoptive Cell Transfer Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2016-2021)
Table 35. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Adoptive Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Adoptive Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 67. Novartis AG Company Details
Table 68. Novartis AG Business Overview
Table 69. Novartis AG Adoptive Cell Transfer Therapy Product
Table 70. Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 71. Novartis AG Recent Development
Table 72. Kite Pharma Company Details
Table 73. Kite Pharma Business Overview
Table 74. Kite Pharma Adoptive Cell Transfer Therapy Product
Table 75. Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 76. Kite Pharma Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Adoptive Cell Transfer Therapy Product
Table 80. Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Juno Therapeutics Company Details
Table 83. Juno Therapeutics Business Overview
Table 84. Juno Therapeutics Adoptive Cell Transfer Therapy Product
Table 85. Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 86. Juno Therapeutics Recent Development
Table 87. Celgene Corporation Company Details
Table 88. Celgene Corporation Business Overview
Table 89. Celgene Corporation Adoptive Cell Transfer Therapy Product
Table 90. Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 91. Celgene Corporation Recent Development
Table 92. CARsgen Therapeutics Company Details
Table 93. CARsgen Therapeutics Business Overview
Table 94. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product
Table 95. CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 96. CARsgen Therapeutics Recent Development
Table 97. Sorrento Therapeutics Company Details
Table 98. Sorrento Therapeutics Business Overview
Table 99. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product
Table 100. Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 101. Sorrento Therapeutics Recent Development
Table 102. Legend Biotech Company Details
Table 103. Legend Biotech Business Overview
Table 104. Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 105. Legend Biotech Recent Development
Table 106. Atara Biotherapeutics Company Details
Table 107. Atara Biotherapeutics Business Overview
Table 108. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product
Table 109. Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 110. Atara Biotherapeutics Recent Development
Table 111. Aurora Biopharma Company Details
Table 112. Aurora Biopharma Business Overview
Table 113. Aurora Biopharma Adoptive Cell Transfer Therapy Product
Table 114. Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 115. Aurora Biopharma Recent Development
Table 116. Autolus Therapeutics PLC Company Details
Table 117. Autolus Therapeutics PLC Business Overview
Table 118. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product
Table 119. Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 120. Autolus Therapeutics PLC Recent Development
Table 121. Bluebird Company Details
Table 122. Bluebird Business Overview
Table 123. Bluebird Adoptive Cell Transfer Therapy Product
Table 124. Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 125. Bluebird Recent Development
Table 126. Carina Biotech Company Details
Table 127. Carina Biotech Business Overview
Table 128. Carina Biotech Adoptive Cell Transfer Therapy Product
Table 129. Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 130. Carina Biotech Recent Development
Table 131. Athenex Company Details
Table 132. Athenex Business Overview
Table 133. Athenex Adoptive Cell Transfer Therapy Product
Table 134. Athenex Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 135. Athenex Recent Development
Table 136. Xiangxue Pharmaceutical (Xiangxue Precision) Company Details
Table 137. Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
Table 138. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product
Table 139. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 140. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
Table 141. Hengrui Yuanzheng Company Details
Table 142. Hengrui Yuanzheng Business Overview
Table 143. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product
Table 144. Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 145. Hengrui Yuanzheng Recent Development
Table 146. Eureka Therapeutics Company Details
Table 147. Eureka Therapeutics Business Overview
Table 148. Eureka Therapeutics Adoptive Cell Transfer Therapy Product
Table 149. Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 150. Eureka Therapeutics Recent Development
Table 151. WuXi Juno Company Details
Table 152. WuXi Juno Business Overview
Table 153. WuXi Juno Adoptive Cell Transfer Therapy Product
Table 154. WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 155. WuXi Juno Recent Development
Table 156. Shenzhen Inno Immunity Company Details
Table 157. Shenzhen Inno Immunity Business Overview
Table 158. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product
Table 159. Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 160. Shenzhen Inno Immunity Recent Development
Table 161. Shenzhen Binde Bio Company Details
Table 162. Shenzhen Binde Bio Business Overview
Table 163. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product
Table 164. Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 165. Shenzhen Binde Bio Recent Development
Table 166. Kerui Bio Company Details
Table 167. Kerui Bio Business Overview
Table 168. Kerui Bio Adoptive Cell Transfer Therapy Product
Table 169. Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 170. Kerui Bio Recent Development
Table 171. Adaptimmune Company Details
Table 172. Adaptimmune Business Overview
Table 173. Adaptimmune Adoptive Cell Transfer Therapy Product
Table 174. Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 175. Adaptimmune Recent Development
Table 176. Altor Bioscience Corporation Company Details
Table 177. Altor Bioscience Corporation Business Overview
Table 178. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product
Table 179. Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
Table 180. Altor Bioscience Corporation Recent Development
Table 181. Cellectis Company Details
Table 182. Cellectis Business Overview
Table 183. Cellectis Adoptive Cell Transfer TherapyProduct
Table 184. Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2016-2021) & (US$ Million)
T

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs